Understanding the difference between SubQ and IM injections can help you feel more confident when discussing treatment options with your provider
The FDA has approved specific GLP-1 medications for type 2 diabetes management and, in higher doses, certain agents (semaglutide 2.4 mg, liraglutide 3 mg, tirzepatide) for chronic weight management in adults with obesity or overweight with at least one weight-related comorbidity
The patient wants to switch to Zepbound because "it's stronger." The argument against: the patient is responding well to current therapy
Largely across society, we dont accept obesity as a long-term chronic disease, and were still looking for quick fixes and quick solutions where thats not the reality of the biology and disease process
Eli Lilly will begin distribution on the 4th through its direct-to-consumer service, LillyDirect, and will later expand to pharmacies and telehealth services
Mechanical approaches Microneedle arrays were created to alleviate the drawbacks of hypodermic needles and to administer drugs that could not diffuse through the skin using passive or externally assisted diffusion [263, 264]